Batch-standardized raw materials produced with high-efficiency fractionation, molecular rectification, and exhaustive GC/HPLC/GC-MS purity validation for global B2B supply lines.
Bridging historical phytotherapy with modern oral medicine: why industrial-grade clove oil (Syzygium aromaticum) remains an irreplaceable active pharmaceutical ingredient for acute odontalgia, pulpal sedation, and antibacterial oral formulations.
Natural clove essential oil exerts its profound odontological anesthetic effect via 4-allyl-2-methoxyphenol (eugenol). Eugenol modulates primary afferent nociceptors by selectively activating and desensitizing Capsaicin receptors (TRPV1) while reversibly inhibiting voltage-gated sodium channels (VGSC) across unmyelinated C-fibers and lightly myelinated A-delta fibers within the dental pulp cavity, rapidly truncating pain impulses.
In reversible and symptomatic irreversible pulpitis, eugenol demonstrates significant suppression of cyclooxygenase-2 (COX-2) enzymatic cascades. By attenuating the production of pro-inflammatory prostaglandin E2 (PGE2) without triggering systemic mucosal ulceration, pharmaceutical clove bud distillates provide targeted anti-inflammatory action directly upon hyperemic dentin and exposed periodontal tissues.
Beyond sensory relief, high-eugenol clove fractions exhibit minimum inhibitory concentrations (MIC) ranging from 0.03% to 0.12% v/v against resistant cariogenic pathogens including Streptococcus mutans, Lactobacillus acidophilus, and Porphyromonas gingivalis. Eugenol's lipophilic phenolic structure disrupts bacterial cell membrane integrity, leaking intracellular ATP and suppressing exopolysaccharide synthesis.
Navigating commercial agricultural origins, secondary rectification paradigms, and mitigating industrial risks stemming from synthetic eugenol substitution and heavy metal adulteration.
| Commercial Grade / Origin | Eugenol Fraction | Extraction Mechanism | Primary Industrial Use Case | Compliance Standards |
|---|---|---|---|---|
| Clove Bud Oil (Ph. Eur. / USP) | 85.0% – 92.0% | Steam Distillation (Rectified) | Direct odontological drops, pulpitis therapy, dental ZOE cement | EP 10.0, USP-NF, FDA 21 CFR §184.1257 |
| Clove Leaf Oil (Industrial Crude) | 72.0% – 82.0% | Field Steam Distillation | Precursor for isolated eugenol isolation, vanillin synthesis | ISO 3141:1997, Industrial Grade |
| Clove Stem Oil (Fractionated) | 80.0% – 88.0% | Direct High-Pressure Steam | Oral antiseptic mouthwashes, periodontal gels, flavor compounding | FCC Food Grade, ISO 3142 |
| Supercritical CO₂ Clove Extract | 88.0% – 95.0% | Dense Phase Supercritical Fluid | Premium clean-label oral tinctures, pediatric OTC micro-gels | Cosmetics EU 1223/2009, Organic USDA/NOP |
While Madagascar and Indonesia dominate unprocessed agricultural biomass, climatic fluctuations and unpredictable artisanal collection create extreme pricing instability and uneven moisture/ash ratios. Leading global healthcare buyers mitigate this supply-chain exposure by engaging specialized secondary processors such as Jiangxi Baicao Pharmaceutical, where raw botanical oleoresins are subjected to industrial fractional distillation, molecular decolorization, and GMP-certified refining.
Petroleum-derived synthetic guaiacol-route eugenol represents an escalating integrity threat in the global market. Petroleum synthetics possess identical molecular weight to natural eugenol but lack therapeutic co-constituents (e.g., natural beta-caryophyllene, eugenyl acetate) and introduce toxic petrochemical byproduct traces. Baicao utilizes routine 14C Carbon Isotope Testing and GC-MS chiral profiling to certify that 100% of our clove oil originates from natural, botanical biomass.
From unstandardized dark tinctures to ultra-stable nano-emulsions, dry eugenol cyclodextrin complexes, and targeted submicron oral drug delivery systems.
Elimination of harsh, oxidizing sesquiterpenes through computer-controlled multi-stage vacuum column fractionation. By tightly regulating boiling points under high vacuum (<5 mbar), eugenyl acetate content is retained precisely between 4.0% and 15.0%, preserving natural enzymatic synergy while producing a limpid, pale yellow distillate exhibiting zero burnt odors and long-term storage clarity.
Development of self-nanoemulsifying drug delivery systems (SNEDDS) featuring mean droplet diameters under 50 nanometers. Using biocompatible non-ionic surfactants, the highly lipophilic clove essential oil is rendered instantly dispersible in saliva and water-based oral mouthwashes, increasing mucosal penetration by 320% without mucosal irritation or ethanol vehicle requirements.
Microencapsulation of eugenol using hydroxypropyl-beta-cyclodextrin (HP-β-CD) inclusion complexes and bioadhesive thermosensitive hydrogels (Poloxamer 407). This innovation transitions liquid volatile clove oil into stable, moisture-triggered powders and localized periodontic depot systems that provide controlled, zero-order analgesia release directly into infected periodontal pockets over 72 hours.
How world-class dental manufacturers convert our high-purity clove oil API into hospital-grade endodontic cements, OTC analgesics, and periodontal clinical applications.
In dental restorative and endodontic protocols, high-assay clove bud oil reacts with zinc oxide powder via a chelation reaction, yielding an insoluble zinc eugenolate matrix. Our oil maintains strict moisture tolerances (<0.2%), preventing premature setting or dimensional contraction while securing optimum setting times (4 to 10 minutes) compliant with ISO 3107.
For consumer over-the-counter temporary toothache emergency kits, our refined clove oil is balanced with cosmetic-grade carrier bases or polyols for measured swab application. The product provides instantaneous desensitization to exposed dentinal tubules prior to definitive endodontic or prosthodontic intervention, compliant with FDA OTC monographs.
Post-extraction alveolar osteitis requires intense local analgesia without systemic toxicity. Clove oil integrated into iodoform dressings or resorbable surgical matrices provides sustained antibacterial suppression against anaerobic spirochetes while continuously suppressing acute trigeminal pain radiating from exposed cortical bone.
Founded in 2010 in the Jinggangshan Economic & Technological Development Area, Ji'an City, Jiangxi Province, China, combining pristine natural flora resources with state-of-the-art pharmaceutical purification infrastructure.
Our campus spans 28,600 m² of specialized pharmaceutical production floor. Workshop 01 is equipped with 6 high-volume essential oil lines running vacuum distillation, rectification, decolorization, and nitrogen-blanketed filling. Workshop 02 houses 6 standardized botanical extract lines engineered for cleanroom crystallization, ultrasonic extraction, and spray drying.
Every batch undergoes strict multi-point analysis before clearance. Our internal QC center features gas chromatography with flame ionization detection (GC-FID), Gas Chromatography-Mass Spectrometry (GC-MS), High-Performance Liquid Chromatography (HPLC), and Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for heavy metal trace quantification.
Jiangxi Baicao Pharmaceutical adheres strictly to ISO 9001 quality management protocols and current Good Manufacturing Practice (cGMP) guidelines. Our facility is registered with the US FDA (Facility Establishment Identifier on record), enabling rapid customs clearance, pre-approved Drug Master File (DMF) technical packages, and seamless regulatory inspections.
Complete regulatory documentation packages designed to satisfy strict oversight bodies including the US FDA, EMA (European Medicines Agency), TGA Australia, and national health authorities.
Every shipment arrives with a verified, batch-specific Certificate of Analysis (COA) containing exact GC-MS chromatogram peaks, a compliant 16-section Safety Data Sheet (GHS/MSDS), Certificate of Origin (COO), IFRA conformity certificate, and certified allergen declarations (limonene, linalool, isoeugenol thresholds).
Because eugenol acts as a powerful plasticizer and solvent, standard industrial containers risk degradation and phthalate contamination. Baicao packages bulk orders exclusively in fluorinated HDPE canisters, epoxy-phenolic lined galvanized steel drums (25 kg / 180 kg UN-approved), or nitrogen-purged Type III amber glass bottles for specialized clinical batches.
Recognizing diverse worldwide market requirements, our manufacturing workflows are certified Halal (MUI/JAKIM compliant) and Kosher. Products are guaranteed non-GMO, zero radiation, TSE/BSE-free, and manufactured without animal testing, satisfying the modern clean-label demands of both Western retail shelves and Asian hospital networks.
Authoritative answers on analytical parameters, safety profiles, shelf-life stability, custom toll distillation, and qualification sample logistics.
Explore our certified range of functional vegetable base oils, cineole-standardized therapeutics, and cold-pressed botanical carriers for commercial formulation teams.
Connect directly with Jiangxi Baicao's chemical engineering and export regulatory team. Request complete technical dossiers, batch GC-MS spectra, pricing contracts, and GMP audit documentation.